Onconic Therapeutics Inc. Stock: price and insider trades · South Korea
온코닉테라퓨틱스
No insider purchase over the last 90 days. The latest, by 한상철, was filed 17 Apr 2026.
Onconic Therapeutics Inc.: what insiders have been doing
Onconic Therapeutics Inc. is a Health Care company. Its directors and officers file their transactions with DART (FSS). The last twelve months, up to 31 October 2026, brought 23 filings signed by 8 insiders.
On the market, 6 insiders bought (15 purchases totalling €794k) while 4 insiders sold (5 sales totalling €7.8M). The totals do not cover 14 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 3 chief executives and 2 board members among the declarants. 제일약품 filed the largest sale, €7.6M, on 4 March 2026, which represents 2.0% of the company's market value.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 23 filings here. The full history, which starts in 2024, counts 27 purchases against 6 sales.
The data flag 2 purchases as part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The latest purchase dates back some time: it was published 206 days ago, on 17 April 2026. Typically, a trade is published a median of 6 days after it takes place. Until a filing is published, the market cannot know about the trade.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySale+1 other insider
Since the insiders bought
- -50.5%Entry ₩24,450 · Close 30 Oct 2026 ₩12,110
- -50.5%Entry ₩24,450 · Close 30 Oct 2026 ₩12,110
- -46.8%Entry ₩22,750 · Close 30 Oct 2026 ₩12,110
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 200,992 sharesShareKRXDART:20260703000621
- 28,577 sharesShareKRXDART:20260612000488
- 20,000 shares@ ₩22,208.000.066% mcap64.9% of flowShareKRXDART:20260506000673
- 22,847 shares@ ₩17,381.000.059% mcap100.0% of flowShareKRXDART:20260417000595Canonical exit: 12 Jul 2026 (T+90)
- 140,000 shares@ ₩2,714.000.057% mcap100.0% of flowShareKRXDART:20260417000005Canonical exit: 9 Jul 2026 (T+90)
- 90,000 shares@ ₩2,667.000.036% mcap35.1% of flowShareKRXDART:20260414002591Canonical exit: 9 Jul 2026 (T+90)
- 130,000 shares@ ₩2,731.000.053% mcap100.0% of flowShareKRXDART:20260413002807Canonical exit: 9 Jul 2026 (T+90)
- 39,000 shares@ ₩8,965.22860.14% mcap100.0% of flowShareKRXDART:20260410002723
- ●Executives0DART
- 756,162 shares1.95% mcap100.0% of flowKRXDART:20260304001398
- 54,018 sharesShareKRXDART:20260226005556Canonical exit: 27 May 2026 (T+90)
- ShareKRXDART:20260119000257
- 150,000 sharesShareKRXDART:20260119000259Canonical exit: 19 Apr 2026 (T+90)
- 13,373 sharesShareKRXDART:20260115000024Canonical exit: 15 Apr 2026 (T+90)
- 17,916,974 sharesKRXDART:20260112000038Canonical exit: 6 Apr 2026 (T+90)
- 131,974 sharesShareKRXDART:20260109000569Canonical exit: 9 Apr 2026 (T+90)
- 20,000,000 sharesShareKRXDART:20260109000520Canonical exit: 9 Apr 2026 (T+90)
- 100,000 sharesShareKRXDART:20260106000579Canonical exit: 6 Apr 2026 (T+90)
- 98,580 sharesShareKRXDART:20260106000582
- 15,754,284 sharesShareKRXDART:20251224000246Canonical exit: 24 Mar 2026 (T+90)
- 5,200 sharesShareKRXDART:20251106000022Canonical exit: 4 Feb 2026 (T+90)
- 7,626 sharesShareKRXDART:20251105000224Canonical exit: 3 Feb 2026 (T+90)
- 30,000 sharesShareKRXDART:20251105000084Canonical exit: 3 Feb 2026 (T+90)
- 5,200 shares@ ₩2,875.002.2% of flowShareKRXDART:20251031000045Canonical exit: 26 Jan 2026 (T+90)
25 of 37 declarations
About Onconic Therapeutics Inc.
Onconic Therapeutics is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments for various diseases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
